Senior Management
Ginette Serrero, PhD | Co-Founder and CEO
Dr. Serrero is CEO of A&G Pharmaceutical, which she co-founded in 2000 based on her discovery of the GP88/PGRN growth factor protein and her pioneering research demonstrating its importance in the tumorigenesis of many cancers. Under her leadership, A&G has advanced seven new therapeutic and diagnostic product candidates into preclinical and clinical development, including two breast cancer diagnostics nearing FDA approval. With more than 25 years of research and development experience in the fields of cell biology and biochemistry, Dr. Serrero is a recognized leader in the field of cancer biology research and development, with particular expertise in cell differentiation, growth factors, adipocyte differentiation, and breast cancer. She is an Adjunct Professor at the University of Maryland School of Pharmacy and at the University of Maryland School of Medicine. Prior to founding A&G, Dr. Serrero was a Professor at the University of Maryland School of Pharmacy and a Professor in the Program in Oncology at the University of Maryland Greenebaum Cancer Center. Before that, she was Senior Scientist at the W. Alton Jones Cell Science Center in Lake Placid. She has published more than 80 papers, invited chapters, and reviews and is the inventor on 40 issued patents and more than 100 pending applications related to obesity and cancer molecular targets. Dr. Serrero is the Associate Editor of In Vitro Cell and Developmental Biology. She is the 2006 recipient of the Greater Baltimore Life Sciences Entrepreneurial Spirit Award and is an advisory board member of the Maryland Industrial Partnerships Program and of the Greater Baltimore Technology Council. Dr. Serrero received a PhD in Biochemistry from the University of Marseille and a DSc in Cell Biology from the University of Nice.
Jun Hayashi, PhD | Co-Founder and VP of Research & Development
Ginette Serrero, PhD | Co-Founder and CEO
Dr. Serrero is CEO of A&G Pharmaceutical, which she co-founded in 2000 based on her discovery of the GP88/PGRN growth factor protein and her pioneering research demonstrating its importance in the tumorigenesis of many cancers. Under her leadership, A&G has advanced seven new therapeutic and diagnostic product candidates into preclinical and clinical development, including two breast cancer diagnostics nearing FDA approval. With more than 25 years of research and development experience in the fields of cell biology and biochemistry, Dr. Serrero is a recognized leader in the field of cancer biology research and development, with particular expertise in cell differentiation, growth factors, adipocyte differentiation, and breast cancer. She is an Adjunct Professor at the University of Maryland School of Pharmacy and at the University of Maryland School of Medicine. Prior to founding A&G, Dr. Serrero was a Professor at the University of Maryland School of Pharmacy and a Professor in the Program in Oncology at the University of Maryland Greenebaum Cancer Center. Before that, she was Senior Scientist at the W. Alton Jones Cell Science Center in Lake Placid. She has published more than 80 papers, invited chapters, and reviews and is the inventor on 40 issued patents and more than 100 pending applications related to obesity and cancer molecular targets. Dr. Serrero is the Associate Editor of In Vitro Cell and Developmental Biology. She is the 2006 recipient of the Greater Baltimore Life Sciences Entrepreneurial Spirit Award and is an advisory board member of the Maryland Industrial Partnerships Program and of the Greater Baltimore Technology Council. Dr. Serrero received a PhD in Biochemistry from the University of Marseille and a DSc in Cell Biology from the University of Nice.
Jun Hayashi, PhD | Co-Founder and VP of Research & Development
© 2009 A&G Pharmaceutical, Inc. All Rights Reserved. | Terms of Use | Privacy
